Close Menu

NEW YORK (360Dx) – Numares confirmed on Wednesday that its test for diagnosing kidney rejection has received CE-IVD marking. The firm has launched it in Europe.

Called renalTX-Score, the test is the first to be available worldwide that evaluates a metabolic biomarker network, rather than single biomarkers or tissue biopsy for diagnosing acute rejection following a kidney transplant, Numares said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.